Editorial by Βy Prof. Daniele Regge, Chief of the Radiology Unit, Candiolo Cancer Institute (FPO) The Clinical Vision of the project and added value for patients One man in eight is diagnosed with prostate cancer during his lifetime and among them, approximately one...
Newsletter #4
Clinical Challenge: Can machine learning and artificial intelligence of primary prostate cancer identify patients at risk of metastatic disease as early as possible?
By Prof Mu Koh, Royal Marsden NHS Foundation Trust (ICR) Primary prostate cancer is a heterogeneous disease in terms of disease aggressiveness and long-term outcomes. Many men who are diagnosed with prostate cancer will have indolent disease and die of other causes....
Prostate cancer MRI as an AI challenge
By Prof Jurgen Futterer & Prof Henkjan Huisman, RadboudUMC (RUN) Professors Jurgen Futterer and Henkjan Huisman are both affiliated with Radboudumc, Nijmegen, The Netherlands. They have a long-standing collaboration and are part of the EU H2020 project ProCAncer-I...
ProCAncer-I eCRF and Data Upload Tools
By Joao Correia, Innovation Manager at Biotronics3D Limited (B3D) The ProCAncer-I eCRF (electronic case report form) and Data Upload Tools support ProCAncer-I clinical partners in the process of compiling the required information and follow the defined protocols for...
The Value of Data in Health Research
By Theresa Henne, University of Vienna (UNIVIE), Clara Saillant University of Vienna (UNIVIE) &Varvara Kalokyri, Foundation for Research and Technology (FORTH) Data is increasingly regarded as a valuable resource, in particular for the development of Big Data and...
Presentation of partner B3D, Biotronics3D Limited
Biotronics3D was established in 2004 in London, opened an R&D Centre in Cambridge in 2009, opened a Central European Operations office in Bucharest in 2014, and established its Innovation Centre in Edinburgh during 2017. Biotronics3D recently integrated the...
Presentation of partner IDIBGI, Fundacio Institut D’Investigacio Biomedica De Girona Doctor Josep Trueta
The Girona Biomedical Research Institute (IDIBGI) aims to promote translational research to improve people's health. Located in Girona area, in Catalonia (Spain), its activity aims to increase knowledge of numerous diseases to improve their diagnosis, treatment and...
Newsletter #4 Contents
Highlights

The ProCAncer-I at the IEEE Engineering in Medicine & Biology Society (EMBS) in Malta
Nov 28, 2023
The ProCAncer-I Consortium is organising a mini symposium under the scope Data Engineering in Cancer, chaired by prof. Dimitris Fotiadis and are inviting every interested stakeholder to participate. The mini symposium will take place during the IEEE EMBS International Conference on Data Science and Engineering in Healthcare, Medicine & Biology, in Malta (Hilton Malta Hotel) on December 7, 2023 – December 9, 2023, on the second day.

ProCAncer-I at the “Al and Cancer: Unleashing Opportunities, Overcoming Challenges” workshop
Nov 16, 2023
240 professionals from more than 20 countries registered for the workshop event ’Al and Cancer: Unleashing Opportunities, Overcoming Challenges’, coorganized by INCISIVE, EUCAIM, and the AI4HI cluster, with the local support of Medtronic and TIC Salut Social Foundation, the 7th of November in Madrid, Spain.

Prof Tsiknakis: Launch of the federal European infrastructure for cancer imaging
Oct 23, 2023
The EUCAIM (European Federation for Cancer Images) project is the cornerstone of the European Cancer Imaging Initiative, launched by the European Commission, within the framework of the European Beating Cancer Plan, emphasized Prof. Manolis Tsiknakis, as Coordinator of the ProCAncer-I project and Affiliated Professor at the Computational Biomedicine Laboratory (CBML), speaking at the Health IT conference.

EUCAIM unveils first release of groundbreaking platform to fuel collaborative innovation and data sharing across Europe
Oct 2, 2023
EUCAIM unveils first release of groundbreaking platform to fuel collaborative innovation and data sharing across Europe